This clinical field investigates the influence of an individual’s unique genetic profile on their susceptibility to, and manifestation of, cardiovascular diseases and related metabolic dysfunction. It involves identifying specific single nucleotide polymorphisms (SNPs) and gene variants that modulate lipid metabolism, blood pressure regulation, and vascular integrity. Understanding these genetic predispositions allows for highly personalized preventative and therapeutic strategies.
Origin
This discipline emerged from the confluence of traditional cardiology and the advancements in human genome sequencing, linking inherited traits to heart disease risk. The term combines the clinical focus of “cardiovascular health” with the foundational science of “genetics.” The Framingham Heart Study and subsequent large-scale genome-wide association studies provided the empirical basis for recognizing the heritable component of cardiac risk factors.
Mechanism
Genetic variants impact cardiovascular health by altering the function of key physiological components, such as the synthesis and receptor binding of lipoproteins, like ApoE. They also influence the efficiency of the Renin-Angiotensin-Aldosterone System (RAAS), affecting blood pressure and fluid balance. Furthermore, genetic variations can dictate the body’s inflammatory response and the capacity for endothelial repair, directly affecting arterial plaque formation and stability.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.